Portfolio company
Kupando
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops small-molecule immunotherapies that stimulate the innate immune system to treat solid tumours and prevent infectious diseases for medical patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
KyDo
This biotechnology company develops small molecule inhibitors for the treatment of cancer variants in oncology patients.
KyDo Therapeutics
This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.
IFM Therapeutics
The company develops small molecule medicines targeting the innate immune system to treat patients with inflammatory diseases and cancer.
Eradivir
This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
1200 Pharma
This biotechnology firm develops small molecule therapies and drug intellectual property for the treatment of cancer patients.
Hookipa Pharma
This biopharmaceutical company develops arenavirus-based immunotherapies to treat infectious diseases and cancers for patients and healthcare providers.
Primmune Therapeutics Inc
This clinical-stage biotechnology company develops orally administered small molecule immunotherapies to treat patients with solid tumours and viral infections.
